Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial

Autor: Tripathy, D. *, Lichinitzer, M., Lazarev, A., MacLachlan, S.A., Apffelstaedt, J., Budde, M., Bergstrom, B.
Zdroj: In Annals of Oncology May 2004 15(5):743-750
Databáze: ScienceDirect